This suggests that neutrophils might be involved in aggravating inflammation and is consistent with studies that show an increase in nonspecific acute-phase CRP and D-dimer inflammatory biomarkers in COVID-19, particularly in patients who subsequently have poor outcomes (45, 46). The gene discussed is CRP; the disease is COVID-19.